Literature DB >> 22506981

Association of symptoms of colon cancer patients with tumor location and TNM tumor stage.

Kristin K Alexiusdottir1, Pall Helgi Möller, Petur Snaebjornsson, Larus Jonasson, Elinborg J Olafsdottir, Einar Stefan Björnsson, Laufey Tryggvadottir, Jon G Jonasson.   

Abstract

OBJECTIVE: Colon cancer is the second most common cause of cancer death in Iceland and accounts for 8% of malignancies. We related information on symptoms of colon cancer patients with information on tumor location and pTNM-stage.
MATERIAL AND METHODS: The study is retrospective and population-based. Information on all patients diagnosed with colon cancer in Iceland in 1995-2004 was obtained. Information on symptoms of patients and blood hemoglobin was collected from patients' files. The pathological parameters were derived from a previously performed study.
RESULTS: A total of 768 patients (422 males, 346 females) participated in this study. Median age was 73 years. Nearly 60% had anemia at the time of diagnosis, 53% had visible blood in stools, and 65% had changes in bowel habits. Around 84% had visible blood in stools and/or anemia. Of those with right-sided tumors, 75% had anemia and were more likely to be diagnosed incidentally (40%) than those with left-sided tumors (20%). Left-sided tumors were associated with blood in stools (68% compared to 41%, p < 0.05) and changes in bowel habits (74% compared to 57%, p < 0.05). Multivariate analysis indicated that blood in stools was strongly associated with a lower TNM-stage (OR = 0.75, p < 0.05). Anemia was strongly associated with a higher TNM-stage (OR = 1.84, p < 0.05).
CONCLUSION: Right-sided tumors were associated with anemia and incidental diagnosis; left-sided tumors were associated with visible blood in stools and changes in bowel habits. Visible blood in stools was significantly associated with lower TNM-stage, whereas abdominal pain, general and acute symptoms were associated with higher TNM-stage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22506981     DOI: 10.3109/00365521.2012.672589

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  19 in total

1.  Safe investigation of isolated change in bowel habit with a flexible sigmoidoscopy? A systematic review and meta-analysis.

Authors:  Pjj Herrod; H Boyd-Carson; B Doleman; Jem Blackwell; Ejo Hardy; F Harper; J N Lund
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

2.  Screening or Symptoms? How Do We Detect Colorectal Cancer in an Equal Access Health Care System?

Authors:  Quinton M Hatch; Kevin R Kniery; Eric K Johnson; Shelly A Flores; David L Moeil; John J Thompson; Justin A Maykel; Scott R Steele
Journal:  J Gastrointest Surg       Date:  2015-12-01       Impact factor: 3.452

3.  Colorectal cancer and the blood loss paradox.

Authors:  Orouba Almilaji; Sally D Parry; Sharon Docherty; Jonathon Snook
Journal:  Frontline Gastroenterol       Date:  2021-10-21

4.  Clinical presentation predicts the outcome of patients with colon cancer.

Authors:  Offir Ben-Ishay; Zvi Peled; Amira Othman; Eran Brauner; Yoram Kluger
Journal:  World J Gastrointest Surg       Date:  2013-04-27

5.  Delays in referral from primary care worsen survival for patients with colorectal cancer: a retrospective cohort study.

Authors:  Chanpreet S Arhi; Elaine M Burns; Alex Bottle; George Bouras; Paul Aylin; Paul Ziprin; Ara Darzi
Journal:  Br J Gen Pract       Date:  2020-06-25       Impact factor: 5.386

6.  A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort.

Authors:  Chuan Liu; Chuan Hu; Jiale Huang; Kanghui Xiang; Zhi Li; Jinglei Qu; Ying Chen; Bowen Yang; Xiujuan Qu; Yunpeng Liu; Guangwei Zhang; Ti Wen
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

7.  Lower Gastrointestinal Bleeding And Risk of Gastrointestinal Cancer.

Authors:  Søren Viborg; Kirstine Kobberøe Søgaard; Dóra Körmendiné Farkas; Helene Nørrelund; Lars Pedersen; Henrik Toft Sørensen
Journal:  Clin Transl Gastroenterol       Date:  2016-04-07       Impact factor: 4.488

8.  Symptoms and signs of colorectal cancer, with differences between proximal and distal colon cancer: a prospective cohort study of diagnostic accuracy in primary care.

Authors:  Knut Holtedahl; Lars Borgquist; Gé A Donker; Frank Buntinx; David Weller; Christine Campbell; Jörgen Månsson; Victoria Hammersley; Tonje Braaten; Ranjan Parajuli
Journal:  BMC Fam Pract       Date:  2021-07-08       Impact factor: 2.497

9.  Investigation of clinical manifestations in korean colorectal cancer patients.

Authors:  Hye Young Koo; Kyu Joo Park; Jae Hwan Oh; Sung Bum Kang; Seong Taek Oh; Woo Yong Lee
Journal:  Ann Coloproctol       Date:  2013-08-29

10.  Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.

Authors:  A Tankiewicz-Kwedlo; J Hermanowicz; A Surażynski; D Rożkiewicz; A Pryczynicz; T Domaniewski; K Pawlak; A Kemona; D Pawlak
Journal:  Mol Cell Biochem       Date:  2016-08-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.